NY Pub Health L § 290 (2021)
2021 New York Laws PBH - Public Health Article 2-B - Drug Take Back 290 - Definitions.

§  290.  Definitions.  As  used  in  this  article, unless the context   clearly requires otherwise:1. "Authorized collector" means: (a) a person, company, corporation or   other entity that is registered with the United States Drug  Enforcement   Administration to collect controlled substances for the purposes of safe   disposal and destruction; (b) a law enforcement agency; or (c) a person,   company,  corporation  or  other  entity authorized by the department to   provide alternative collection methods for covered drugs  that  are  not   controlled substances.2.  "Covered  drug"  means any substance recognized as a drug under 21   USC § 321(g)(1), as amended, and any regulations promulgated  thereunder   that  is  sold,  offered  for  sale  or  dispensed in the state, whether   directly or through a wholesaler, in any form including prescription and   nonprescription  drugs,  drugs  in  medical  devices   and   combination   products, brand and generic drugs and drugs for veterinary use; provided   however,  covered  drug  shall not include: (a) vitamins or supplements;   (b) herbal-based remedies and homeopathic drugs, products  or  remedies;   (c)  cosmetics,  soap  (with  or  without  germicidal  agents),  laundry   detergent, bleach, household cleaning  products,  shampoos,  sunscreens,   toothpaste,  lip  balm,  antiperspirants or other personal care products   that are regulated as both cosmetics and nonprescription drugs under the   Federal Food,  Drug,  and  Cosmetic  Act;  (d)  pet  pesticide  products   contained  in  pet  collars, powders, shampoos, topical applications, or   other forms; (e) drugs  that  are  biological  products  as  defined  in   subdivision  twenty-seven  of  section  sixty-eight  hundred  two of the   education law if the manufacturer already provides a take back  program;   (f)  drugs for which a manufacturer provides a take back program as part   of a Federal Food and Drug Administration managed  risk  evaluation  and   mitigation  strategy;  (g)  emptied injector products or emptied medical   devices and their component parts or accessories; and (h) drugs that are   used solely in a clinical setting.3. "Manufacturer" means a person, company, corporation or other entity   engaged  in  the  manufacture  of  covered  drugs  sold  in  the  state.   Manufacturer does not include a repackager or wholesaler.4.   "Pharmacies"   means  all  pharmacies  registered  under  section   sixty-eight hundred eight of the education law that are part of a  group   of ten or more establishments that conduct business under the same name,   or  operate  under  a  common  ownership or management, or pursuant to a   franchise agreement  with  the  same  franchisor,  and  all  nonresident   pharmacies registered pursuant to section sixty-eight hundred eight-b of   the education law that provide covered drugs to state residents by mail.5. "Drug take back organization" means an organization designated by a   manufacturer or a group of manufacturers to act as an agent on behalf of   the  manufacturer  or  group of manufacturers to operate and implement a   drug take back program as authorized by this article.6. "Wholesaler" means any person, company, corporation or other entity   that sells or distributes drugs and  covered  drugs  for  resale  to  an   entity in the state other than a consumer.7. "Repackager" means an entity that owns or operates an establishment   that repacks and relabels a product or package containing a covered drug   for further sale or for distribution without further transaction.